active

Grey Wolf Therapeutics

10989365 First deal Jan 2023

Deals

£76M

Total Capital Raised/Funded

Deal History

VC Funding Series B 23 May 2024

Investor: Pfizer Ventures, Andera Partners, ICG’s Life Sciences, Earlybird Venture Capital, Oxford Science Enterprises, British Patient Capital, Canaan

£36M

VC Funding Series B 26 Jan 2023

Investor: Oxford Science Enterprises, Canaan, Earlybird Venture Capital, Andera Partners, British Patient Capital, Pfizer Ventures

£40M

Funding Timeline

January 2023

VC Funding Series B £40M

Oxford Science Enterprises, Canaan, Earlybird Venture Capital, Andera Partners, British Patient Capital, Pfizer Ventures

May 2024

VC Funding Series B £36M

Pfizer Ventures, Andera Partners, ICG’s Life Sciences, Earlybird Venture Capital, Oxford Science Enterprises, British Patient Capital, Canaan

Financial History

Directors & Officers

Companies House